Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(4h)-one
2. Onc201
3. Tic10 Compound
4. Trail-inducing Compound 10
1. 1616632-77-9
2. Onc 201
3. Onc-201
4. Onc201
5. Nsc-350625
6. 9u35a31jai
7. Mfcd28118993
8. 11-benzyl-7-[(2-methylphenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one
9. 1342897-86-2
10. Active Isomer 2
11. Tic10 Compound
12. 7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(4h)-one
13. Angular Tic10
14. Tic10 Active Isomer
15. Unii-9u35a31jai
16. Gtpl9978
17. Tic10?
18. Chembl4297310
19. Onc 201 [who-dd]
20. Schembl16227974
21. Ex-a669
22. Hms3874g13
23. Bcp14991
24. Hy-15615a
25. Nsc784931
26. S7963
27. Zinc169620396
28. Ccg-264705
29. Cs-3564
30. Db14844
31. Nsc 350625
32. Nsc-784931
33. Sb17110
34. Ncgc00386747-03
35. Ncgc00386747-06
36. Ncgc00386747-09
37. Ncgc00386747-10
38. As-16735
39. Sy242153
40. Ft-0700231
41. A883070
42. J-690224
43. Q27895916
44. 2,4,6,7,8,9-hexahydro-4-((2-methylphenyl)methyl)-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one
45. 2,4,6,7,8,9-hexahydro-4-((2-methylphenyl)methyl)-7-phenylmethyl)imidazo)(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one
| Molecular Weight | 386.5 g/mol |
|---|---|
| Molecular Formula | C24H26N4O |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 386.21066147 g/mol |
| Monoisotopic Mass | 386.21066147 g/mol |
| Topological Polar Surface Area | 39.2 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 693 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
A ONC201 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ONC201, including repackagers and relabelers. The FDA regulates ONC201 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ONC201 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ONC201 supplier is an individual or a company that provides ONC201 active pharmaceutical ingredient (API) or ONC201 finished formulations upon request. The ONC201 suppliers may include ONC201 API manufacturers, exporters, distributors and traders.
ONC201 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ONC201 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ONC201 GMP manufacturer or ONC201 GMP API supplier for your needs.
A ONC201 CoA (Certificate of Analysis) is a formal document that attests to ONC201's compliance with ONC201 specifications and serves as a tool for batch-level quality control.
ONC201 CoA mostly includes findings from lab analyses of a specific batch. For each ONC201 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ONC201 may be tested according to a variety of international standards, such as European Pharmacopoeia (ONC201 EP), ONC201 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ONC201 USP).
LOOKING FOR A SUPPLIER?
